Isolation of an early T-cell precursor (CFU-TL) from human bone marrow.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 1689596)

Published in Blood on March 01, 1990

Authors

J M Bertho1, M D Mossalayi, A H Dalloul, G Mouterde, P Debre

Author Affiliations

1: Laboratoire d'Immunologie Cellulaire, CNRS URA 186, hôpital Pitié-Salpètrière, Paris, France.

Articles by these authors

The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc Natl Acad Sci U S A (1995) 1.88

T cell receptor gamma/delta+ lymphocyte subsets during HIV infection. Clin Exp Immunol (1989) 1.72

Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol (2001) 1.65

Sequences and diversity of human T cell receptor beta chain variable region genes. J Exp Med (1986) 1.62

Expression, structure, and function of the CD23 antigen. Adv Immunol (1991) 1.46

Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol (1997) 1.46

Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. J Clin Invest (1992) 1.43

T lymphocyte subsets in primary antiphospholipid syndrome. J Rheumatol (1994) 1.43

Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients. AIDS (1988) 1.37

Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. J Immunol (1989) 1.33

Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group. AIDS (1997) 1.30

Involvement of cyclic AMP and nitric oxide in immunoglobulin E-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes. J Clin Invest (1994) 1.29

Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation. J Exp Med (1990) 1.26

CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection. Blood (1992) 1.23

Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol Today (1995) 1.20

Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23. Blood (1990) 1.15

IgE-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes: the role of cAMP and nitric oxide. Cell Mol Biol (Noisy-le-grand) (1994) 1.07

Critical analysis of T cell subset and function evaluation in patients with persistent generalized lymphadenopathy in groups at risk for AIDS. Clin Exp Immunol (1984) 1.04

A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. Blood (1991) 1.04

Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. J Clin Invest (1990) 1.02

Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation. J Immunol (1992) 1.02

Fully functional NK cells after unrelated cord blood transplantation. Leukemia (2009) 1.01

Increased lung epithelial permeability in HIV-infected patients with isolated cytotoxic T-lymphocytic alveolitis. Am Rev Respir Dis (1990) 1.00

Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia. Int Immunol (2000) 0.98

Genetic control of sensitivity to Moloney leukemia virus in mice. IV. Phenotypic heterogeneity of the leukemic mice. J Immunol (1980) 0.98

CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential. Blood (1993) 0.97

Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol (1990) 0.97

Interleukin-7 is a growth factor for Sézary lymphoma cells. J Clin Invest (1992) 0.96

Agar human T cell colony growth promoted by a B + null cell-derived lymphokine distinct from IL 2. J Immunol (1985) 0.96

Human trophoblast cells express CD4 and are permissive for productive infection with HIV-1. Clin Exp Immunol (1992) 0.95

Alveolar CD8+CD57+ lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions. Am J Respir Crit Care Med (1994) 0.95

Consistency of routine measurements of CD4+, CD8+ peripheral blood lymphocytes. J Immunol Methods (1992) 0.95

Cytokine effects of CD23 are mediated by an epitope distinct from the IgE binding site. EMBO J (1992) 0.94

Evidence for expression of two distinct T cell receptor beta-chain transcripts in a human diphtheria toxoid-specific T cell clone. J Immunol (1988) 0.94

Conjunctival biopsy in Sjögren's syndrome: correlations between histological and immunohistochemical features. Histopathology (1988) 0.93

Synergistic effect of interleukin 1 and soluble CD23 on the growth of human CD4+ bone marrow-derived T cells. Eur J Immunol (1991) 0.93

CCR5 delta32 deletion and reduced risk of toxoplasmosis in persons infected with human immunodeficiency virus type 1. The SEROCO-HEMOCO-SEROGEST Study Groups. J Infect Dis (1999) 0.93

Genetic control of sensitivity to Moloney leukemia virus in mice. II. Mapping of three resistant genes within the H-2 complex. J Immunol (1979) 0.91

Induction of IL-10 synthesis by human keratinocytes through CD23 ligation: a cyclic adenosine 3',5'-monophosphate-dependent mechanism. J Immunol (1997) 0.91

Expression of MHC class II and Tac antigens on IL2-activated human T cell clones that can stimulate in MLR, AMLR, PLT and can present antigen. Hum Immunol (1986) 0.91

Differential effect of transforming growth factor-beta 1 on the activation of human naive and memory CD4+ T lymphocytes. Int Immunol (1994) 0.90

Interleukin-10 inhibits IgE-mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytes. Eur J Immunol (1995) 0.90

Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood (1996) 0.89

Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol (1989) 0.89

Evidence for direct interaction between mast cells and Leishmania parasites. Parasite Immunol (1997) 0.89

Human thymic epithelial cells produce interleukin-3. Blood (1991) 0.88

[Waldenstrôm's macroglobulinemia. Developmental and prognostic study]. Sem Hop (1975) 0.88

Identification of a pure splenic form of chronic lymphocytic leukaemia. Br J Haematol (1979) 0.87

The role of CD23 on early human hematopoietic precursors. Monogr Allergy (1991) 0.87

Functional heterogeneity of B-CLL lymphocytes: dissociated responsiveness to growth factors and distinct requirements for a first activation signal. Blood (1987) 0.86

Detection of apoptosis at the single-cell level by direct incorporation of fluorescein-dUTP in DNA strand breaks. Biotechniques (1996) 0.86

MS-8209, a new Amphotericin B derivative that inhibits HIV-1 replication in vitro and restores T-cell activation via the CD3/TcR in HIV-infected CD4+ cells. AIDS (1991) 0.86

IL-4 release by human leukemic and activated normal basophils. J Immunol (1993) 0.86

Role of nitric oxide in the anti-tumoral effect of retinoic acid and 1,25-dihydroxyvitamin D3 on human promonocytic leukemic cells. Blood (1996) 0.86

Mechanism of anti-inflammatory action of retinoids on keratinocytes. Lancet (1994) 0.85

T-lymphocyte progenitors in man: phenotypic characterization of blood and bone marrow T-colony forming cells. Immunology (1985) 0.85

HLA-E upregulation on IFN-gamma-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT. Bone Marrow Transplant (2008) 0.85

Thymic epithelial cell-derived supernatants sustain the maturation of human prothymocytes: involvement of interleukin 1 and CD23. Eur J Immunol (1991) 0.85

Effects of the molecular weight of peg molecules (8, 20 and 35 KDA) on cell function and allograft survival prolongation in pancreatic islets transplantation. Transplant Proc (2006) 0.85

Involvement of Fc epsilon RII/CD23 and L-arginine dependent pathway in IgE-mediated activation of human eosinophils. Biochem Biophys Res Commun (1994) 0.84

The management of thirty immunocompromised patients with tuberculosis. Am Rev Respir Dis (1984) 0.84

Cellular responses to Loa loa experimental infection in mandrills (Mandrillus sphinx) vaccinated with irradiated infective larvae. Parasite Immunol (2000) 0.83

Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection. J Virol (1999) 0.83

Genetic control of antinuclear antibodies in mice inoculated with the moloney leukaemia virus. J Immunogenet (1981) 0.83

IL-4 inhibits the expression of high affinity IL-2 receptors on monoclonal human B cells. J Immunol (1990) 0.83

Synergistic effect of recombinant IL 2 and interferon-gamma on the proliferation of human monoclonal lymphocytes. J Immunol (1987) 0.83

[Waldenström's macroglobulinemia with preserved antierythrocyte and antilipoprotein antibody activity]. Sem Hop (1975) 0.82

[Lymphocytic alveolitis in the early stages of HIV infection: correlation with biological and prognostic factors]. Rev Mal Respir (1992) 0.82

Comparison of blocking effects of monoclonal antibodies anti-MO1-alpha and anti-LFA1-alpha on human neutrophil functions. Immunology (1987) 0.82

Factor requirements for activation and proliferation steps of human CD2+CD3-CD4-CD8- early thymocytes. Eur J Immunol (1989) 0.82

Maturation of acute T-lymphoblastic leukemia cells after CD2 ligation and subsequent treatment with interleukin-2. Blood (1994) 0.82

Monoclonal B-cell response to diphtheria toxoid: evidence for cross-reactive epitopes. Immunology (1987) 0.82

Stathmin phosphorylation patterns discriminate between distinct transduction pathways of human T lymphocyte activation through CD2 triggering. FEBS Lett (1991) 0.81

CD1 stimulation of human T cell lines induces a rapid increase in the intracellular free Ca2+ concentration and the production of IL-2. J Immunol (1990) 0.81

CD23-mediated nitric oxide synthase pathway induction in human keratinocytes is inhibited by retinoic acid derivatives. J Invest Dermatol (1996) 0.81

CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef. J Immunol (1995) 0.81

Gene therapy approaches to HIV-infection: immunological strategies: use of T bodies and universal receptors to redirect cytolytic T-cells. Front Biosci (1999) 0.81

Differential inhibition of human antigen-specific T cell clone proliferative responses by distinct monoclonal anti-HLA-DR antibodies. J Immunol (1984) 0.81

Distribution of HIV-1 disease modifying regulated on activation normal T cell expressed and secreted haplotypes in Asian, African and Caucasian individuals. French ALT and IMMUNOCO Study Group. AIDS (1999) 0.81

Nitric oxide and human infectious diseases. Res Immunol (1996) 0.81

Inducible nitric oxide synthase and proinflammatory cytokine expression by human keratinocytes during acute urticaria. Mol Med (1997) 0.81

Identification of mature and immature human thymic dendritic cells that differentially express HLA-DR and interleukin-3 receptor in vivo. J Leukoc Biol (2000) 0.81

MHC-restricted cytotoxicity against HIV. J Acquir Immune Defic Syndr (1991) 0.81

T-lymphocyte progenitors in man: biochemical characterization of a colony promoting activity (CPA) active on immature precursors. Immunology (1984) 0.81

Epidermal keratinocyte-derived basophil promoting activity. Role of interleukin 3 and soluble CD23. J Clin Invest (1992) 0.80

Malvidin-3-O-β glucoside, major grape anthocyanin, inhibits human macrophage-derived inflammatory mediators and decreases clinical scores in arthritic rats. Biochem Pharmacol (2013) 0.80

Role of IgE immune complexes in the regulation of HIV-1 replication and increased cell death of infected U1 monocytes: involvement of CD23/Fc epsilon RII-mediated nitric oxide and cyclic AMP pathways. Mol Med (1996) 0.80

Positive effects of interferon-alpha on B cell-type chronic lymphocytic leukemia proliferative response. J Immunol (1988) 0.80

Syngeneic anti-idiotypes against monoclonal anti-HLA-DR antibodies: characterization of recurrent idiotopes. J Immunol (1983) 0.80

Letter: Treatment of inhibitors to factor VIII with activated prothrombin concentrate. N Engl J Med (1974) 0.80

Signal requirements for the generation of T-lymphocytes from T-depleted bone marrow cells: a sequential study. Exp Hematol (1989) 0.79

Studies on human prothymocytes by means of an agar T-cell colony assay. Exp Hematol (1986) 0.79

Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide. Cancer Res (2001) 0.79

CD2 triggering stimulates a phospholipase A2 activity beside the phospholipase C pathway in human T lymphocytes. J Immunol (1990) 0.79

Cyclic AMP- and inositol phosphate-independent inhibition of Ca2+ influx by cholera toxin in CD3-stimulated Jurkat T cells. A study with a cholera toxin-resistant cell variant and the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin. J Immunol (1991) 0.79

Apoptosis and expression of soluble Fas mRNA in systemic lupus erythematosus. Lupus (1998) 0.79

CD 1-8 antigens on human diphtheria toxoid T lymphocyte clones: expression and modulation by TPA, sodium butyrate, and 5-azacytidine. Hum Immunol (1986) 0.78

Theophylline-induced B-CLL apoptosis is partly dependent on cyclic AMP production but independent of CD38 expression and endogenous IL-10 production. Leukemia (1999) 0.78